Loading clinical trials...
Loading clinical trials...
The Influence of Radiofrequency-assisted Hepatectomy on the Perioperative Outcomes and the Long-term Prognosis of HCC With Cirrhosis:A Prospective Randomized Controlled Trial
Surgical resection is the most effective treatment of primary and secondary liver tumors. Technical innovations have mainly focused on minimizing bleeding during transection of the hepatic parenchyma because excessive hemorrhage and the need for blood transfusion are associated with increased postoperative morbidity and mortality. Recently,radiofrequency-assisted(RFA)hepatectomy has developed rapidly and gained widespread acceptance for the treatment of hepatocellular carcinomas(HCC),but its influence on the prognosis of HCC patients,especially for those with cirrhosis,is still controversial. Therefore, we design this prospective clinical trial to explore the effect of RFA hepatectomy versus the conventional hepatectomy on the outcomes of perioperative period and prognosis of HCC patients with cirrhosis.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Institute of Hepatobiliry surgery,Southwest Hospital
Chongqing, Chongqing Municipality, China
Start Date
November 1, 2013
Primary Completion Date
November 1, 2017
Completion Date
December 1, 2018
Last Updated
November 24, 2015
200
ESTIMATED participants
Radiofrequency-assisted Hepatectomy
PROCEDURE
Conventional Hepatectomy
PROCEDURE
Lead Sponsor
Southwest Hospital, China
NCT06811116
NCT06066138
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions